Chimerix Company Profile (NASDAQ:CMRX)

About Chimerix

Chimerix logoChimerix, Inc. (Chimerix) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral antivirals. The Company, based on its lipid conjugate technology, has developed its lead compound, brincidofovir (BCV, CMX001), which is in Phase III clinical development. In addition, the Company has an active discovery program focusing on viral targets for which limited or no therapies are available. Brincidofovir is an investigational oral nucleotide analog that has shown spectrum antiviral activity against over five families of double-stranded deoxyribonucleic acid (dsDNA) viruses that affect humans. CMX157, is its second clinical-stage nucleotide analog, uses the same lipid technology as brincidofovir to deliver high intracellular concentrations of the potent antiviral drug, tenofovir. Tenofovir is marketed under the brand name Viread. The Company has discovered, developed and selected a clinical candidate, CMX669, for BK virus and cytomegalovirus.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CMRX
  • CUSIP:
Key Metrics:
  • Previous Close: $4.76
  • 50 Day Moving Average: $5.174
  • 200 Day Moving Average: $4.779
  • 52-Week Range: $3.50 - $43.37
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.55
  • P/E Growth: 0.000
  • Market Cap: $211.43M
  • Outstanding Shares: 46,214,000
  • Beta: 1.32
  • Net Margins: -1,356.50%
  • Return on Equity: -34.75%
  • Return on Assets: -33.16%
  • Current Ratio: 26.41%
  • Quick Ratio: 26.41%
Additional Links:
Companies Related to Chimerix:

Analyst Ratings

Consensus Ratings for Chimerix (NASDAQ:CMRX) (?)
Ratings Breakdown: 1 Sell Rating, 9 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $13.40 (181.51% upside)

Analysts' Ratings History for Chimerix (NASDAQ:CMRX)
DateFirmActionRatingPrice TargetDetails
8/18/2016Piper Jaffray Cos.Set Price TargetBuy$12.00View Rating Details
8/9/2016JPMorgan Chase & Co.Reiterated RatingHold$7.00View Rating Details
8/9/2016FBR & CoLower Price TargetMkt Perform$9.00 -> $8.00View Rating Details
3/1/2016Citigroup Inc.Reiterated RatingHoldView Rating Details
2/23/2016William BlairLower Price TargetMarket Perform$12.00 -> $8.00View Rating Details
2/23/2016Barclays PLCDowngradeOverweight -> Equal Weight$12.00 -> $6.00View Rating Details
2/22/2016Morgan StanleyDowngradeEqual Weight -> Underweight$8.00 -> $5.00View Rating Details
1/3/2016Brean CapitalDowngradeHoldView Rating Details
1/3/2016Cowen and CompanyDowngradeHoldView Rating Details
1/3/2016Stifel NicolausDowngradeHoldView Rating Details
12/30/2015EmpireReiterated RatingEqual WeightView Rating Details
12/30/2015Janney Montgomery ScottLower Price TargetNeutral$14.00View Rating Details
9/8/2015Cantor FitzgeraldReiterated RatingBuy$57.00View Rating Details
(Data available from 10/21/2014 forward)


Earnings History for Chimerix (NASDAQ:CMRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q2($0.51)($0.39)$1.98 million$1.80 millionViewN/AView Earnings Details
5/9/2016Q1($0.66)($0.57)$2.79 million$1.20 millionViewN/AView Earnings Details
2/29/2016Q415($0.14)($0.82)$8.07 million$3.10 millionViewListenView Earnings Details
11/5/2015Q315($0.59)($0.70)$5.01 million$2.27 millionViewListenView Earnings Details
8/6/2015Q215($0.58)($0.59)$1.37 million$4.10 millionViewListenView Earnings Details
5/11/2015Q115($0.59)($0.54)$1.19 million$1.20 millionViewListenView Earnings Details
3/6/2015Q414($0.51)($0.52)$1.20 millionViewListenView Earnings Details
11/7/2014Q314($0.41)($0.47)$1.19 millionViewN/AView Earnings Details
8/7/2014Q214($0.44)($0.39)ViewN/AView Earnings Details
5/9/2014Q1 14($0.36)($0.39)$0.85 million$0.78 millionViewN/AView Earnings Details
3/7/2014Q413($0.41)($0.31)$1.19 million$0.88 millionViewN/AView Earnings Details
11/14/2013Q3($0.38)($0.26)ViewListenView Earnings Details
8/14/2013Q2 2013($0.40)($0.91)$1.91 million$0.81 millionViewN/AView Earnings Details
5/13/2013Q1 2013($2.43)($22.58)$1.00 million$1.80 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Chimerix (NASDAQ:CMRX)
Current Year EPS Consensus Estimate: $-1.88 EPS
Next Year EPS Consensus Estimate: $-1.87 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.80)($0.45)($0.67)
Q2 20162($0.49)($0.48)($0.49)
Q3 20162($0.36)($0.35)($0.36)
Q4 20162($0.38)($0.33)($0.36)
(Data provided by Zacks Investment Research)


Dividend History for Chimerix (NASDAQ:CMRX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Chimerix (NASDAQ:CMRX)
Insider Ownership Percentage: 10.50%
Institutional Ownership Percentage: 66.13%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2016John M LeonardDirectorSell5,000$5.03$25,150.00View SEC Filing  
8/29/2016M Michelle BerreyInsiderBuy22,417$4.47$100,203.99View SEC Filing  
6/24/2016Ernest MarioDirectorBuy50,000$3.70$185,000.00View SEC Filing  
6/24/2016M Michelle BerreyCEOBuy13,188$3.69$48,663.72View SEC Filing  
5/13/2016Ernest MarioDirectorBuy10,000$4.53$45,300.00View SEC Filing  
5/11/2016Ernest MarioDirectorBuy25,000$4.85$121,250.00View SEC Filing  
5/10/2016Ernest MarioDirectorBuy800$4.76$3,808.00View SEC Filing  
3/16/2016Ernest MarioDirectorBuy25,000$5.06$126,500.00View SEC Filing  
3/15/2016Ernest MarioDirectorBuy20,000$5.13$102,600.00View SEC Filing  
3/1/2016Martha J DemskiDirectorBuy10,000$4.89$48,900.00View SEC Filing  
12/29/2015Ernest MarioDirectorBuy125,000$7.09$886,250.00View SEC Filing  
11/2/2015Martha J. DemskiDirectorSell1,126$41.35$46,560.10View SEC Filing  
10/1/2015Martha J. DemskiDirectorSell2,000$37.68$75,360.00View SEC Filing  
9/1/2015Martha J. DemskiDirectorSell2,000$48.18$96,360.00View SEC Filing  
8/21/2015John M LeonardDirectorBuy1,000$47.38$47,380.00View SEC Filing  
7/17/2015Timothy W TrostCFOSell28,000$50.00$1,400,000.00View SEC Filing  
7/1/2015Martha J DemskiDirectorSell2,000$46.03$92,060.00View SEC Filing  
6/1/2015Martha J DemskiDirectorSell2,000$41.58$83,160.00View SEC Filing  
5/1/2015Martha J DemskiDirectorSell2,000$34.71$69,420.00View SEC Filing  
3/2/2015Martha J DemskiDirectorSell2,000$40.18$80,360.00View SEC Filing  
2/2/2015Martha J DemskiDirectorSell2,000$38.38$76,760.00View SEC Filing  
1/2/2015Martha J DemskiDirectorSell2,000$41.08$82,160.00View SEC Filing  
11/5/2014John M LeonardDirectorBuy4,000$29.00$116,000.00View SEC Filing  
9/25/2014Timothy W TrostCFOSell5,000$27.75$138,750.00View SEC Filing  
9/11/2014James NiedelDirectorSell1,099,949$29.39$32,327,501.11View SEC Filing  
9/9/2014Sanderling Venture Partners V,Major ShareholderSell122,950$29.28$3,599,976.00View SEC Filing  
9/8/2014Timothy WollaegerDirectorSell100,000$24.54$2,454,000.00View SEC Filing  
9/5/2014Ernest MarioDirectorBuy10,000$23.19$231,900.00View SEC Filing  
8/25/2014Timothy W TrostCFOSell5,000$25.13$125,650.00View SEC Filing  
7/25/2014Timothy W TrostInsiderSell5,000$22.35$111,750.00View SEC Filing  
6/25/2014Timothy W TrostCFOSell5,000$22.74$113,700.00View SEC Filing  
5/27/2014Ernest MarioDirectorBuy10,000$14.22$142,200.00View SEC Filing  
5/27/2014M Michelle BerreyInsiderBuy14,065$14.22$200,004.30View SEC Filing  
5/27/2014Timothy W TrostCFOSell5,000$17.41$87,050.00View SEC Filing  
4/25/2014Timothy W TrostInsiderSell5,000$18.67$93,350.00View SEC Filing  
3/25/2014Timothy W TrostCFOSell5,000$25.37$126,850.00View SEC Filing  
2/25/2014Timothy W TrostCFOSell5,000$19.29$96,450.00View SEC Filing  
1/27/2014Timothy W TrostCFOSell5,000$18.26$91,300.00View SEC Filing  
12/26/2013Timothy W TrostCFOSell5,000$15.21$76,050.00View SEC Filing  
12/13/2013Ernest MarioDirectorBuy5,000$13.90$69,500.00View SEC Filing  
12/9/2013Rodman L DrakeDirectorBuy1,000$14.35$14,350.00View SEC Filing  
11/25/2013Ernest MarioDirectorBuy8,000$15.20$121,600.00View SEC Filing  
11/19/2013Ernest MarioDirectorBuy7,500$15.25$114,375.00View SEC Filing  
11/15/2013Rodman L DrakeDirectorBuy1,000$15.56$15,560.00View SEC Filing  
10/25/2013Timothy W TrostCFOSell5,000$16.04$80,200.00View SEC Filing  
10/23/2013Leaf Ventures Ii L.P. NewMajor ShareholderSell585,602$15.51$9,082,687.02View SEC Filing  
10/23/2013Vii L P CanaanDirectorSell674,771$15.51$10,465,698.21View SEC Filing  
8/30/2013Ernest MarioDirectorBuy5,064$15.82$80,112.48View SEC Filing  
8/26/2013Ernest MarioDirectorBuy5,960$17.20$102,512.00View SEC Filing  
8/23/2013M Michelle BerreyInsiderBuy5,540$18.70$103,598.00View SEC Filing  
8/20/2013Ernest MarioDirectorBuy4,040$17.48$70,619.20View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Chimerix (NASDAQ:CMRX)
News Icon2 Biotech Stocks News And Price Trends: ACADIA Pharmaceuticals (NASDAQ:ACAD), Chimerix (NASDAQ:CMRX) - The Voice Registrar (NASDAQ:CMRX) - October 21 at 12:37 PM logoETF’s with exposure to Chimerix, Inc. : October 21, 2016 (NASDAQ:CMRX) - October 21 at 12:37 PM
News IconConsensus Take: Chimerix, Inc. (NASDAQ:CMRX) Earnings & Ratings Watch - CSZ News (NASDAQ:CMRX) - October 20 at 3:48 PM
News IconShare Value Diminishing Over Past Month: Chimerix, Inc. (NASDAQ:CMRX) - CSZ News (NASDAQ:CMRX) - October 16 at 9:00 AM
News IconAlps Advisors Inc. decides to keep it stake in Chimerix Inc. (CMRX ... - DailyQuint (NASDAQ:CMRX) - October 16 at 9:00 AM
News IconVirginia Retirement Systems ET AL Takes Position in Chimerix Inc. (CMRX) - DailyQuint (NASDAQ:CMRX) - October 15 at 9:06 AM logoEPS Estimate Of Chimerix, Inc. (NASDAQ:CMRX) At $-0.56 - Investor Newswire (NASDAQ:CMRX) - October 12 at 9:38 PM
News IconLatest Analyst Ratings For Chimerix, Inc. (CMRX) - The De Soto Edge (NASDAQ:CMRX) - October 10 at 9:01 AM
News IconStreet Target Update on Chimerix, Inc. (NASDAQ:CMRX) - Recall News (NASDAQ:CMRX) - October 6 at 9:53 AM
News IconChimerix, Inc. (CMRX) Updated Broker Price Targets - The De Soto ... - The De Soto Edge (NASDAQ:CMRX) - October 3 at 9:06 AM
News IconChimerix, Inc. (CMRX) Updated Broker Ratings - NewsDen (NASDAQ:CMRX) - September 28 at 9:10 AM logoETF’s with exposure to Chimerix, Inc. : September 27, 2016 (NASDAQ:CMRX) - September 27 at 4:17 PM
News IconBiotech Stocks Worth a Closer Look: Curis, Inc. (NASDAQ:CRIS), Chimerix, Inc. (NASDAQ:CMRX) - The Voice Registrar (NASDAQ:CMRX) - September 22 at 9:53 AM
News IconNews review of 2 biotech stocks: Radius Health, Inc. (NASDAQ:RDUS), Chimerix, Inc. (NASDAQ:CMRX) - The Voice Registrar (NASDAQ:CMRX) - September 22 at 9:53 AM
News IconStock to Watch: DHI Group, Inc. (NYSE:DHX), Chimerix, Inc. (NASDAQ:CMRX) - Newburgh Press (NASDAQ:CMRX) - September 19 at 5:04 PM
News IconBiotech Stocks Worth a Closer Look: Puma Biotechnology, Inc. (NYSE:PBYI), Chimerix, Inc. (NASDAQ:CMRX) - The Voice Registrar (NASDAQ:CMRX) - September 19 at 5:04 PM
News IconHot Biotech Stocks Recap: ImmunoGen, Inc. (NASDAQ:IMGN), Chimerix, Inc. (NASDAQ:CMRX) - The Voice Registrar (NASDAQ:CMRX) - September 17 at 9:00 AM
News IconTwo Biotechnology Names Are Hot: Chimerix, Inc. (CMRX ... - The Independent Republic (NASDAQ:CMRX) - September 16 at 4:09 PM
News IconChimerix, Inc. (NASDAQ:CMRX) Sale Analysis - Newburgh Press (NASDAQ:CMRX) - September 16 at 4:09 PM
News IconPlacing Chimerix, Inc. (NASDAQ:CMRX) Shares Under the Microscope - Post News (NASDAQ:CMRX) - September 9 at 9:06 AM logoETF’s with exposure to Chimerix, Inc. : September 8, 2016 (NASDAQ:CMRX) - September 8 at 4:11 PM
News IconInsider Trading Activity in: Chimerix Inc (CMRX) - The Voice Registrar (NASDAQ:CMRX) - September 7 at 7:53 AM logoChimerix to Present at the Morgan Stanley Global Healthcare Conference (NASDAQ:CMRX) - September 6 at 9:11 AM logoETF’s with exposure to Chimerix, Inc. : August 26, 2016 (NASDAQ:CMRX) - August 26 at 10:53 AM
News IconChimerix Inc (NASDAQ:CMRX): What We're Looking For From Its Upcoming Data - Street Register (NASDAQ:CMRX) - August 23 at 9:30 PM
News IconChimerix Inc (NASDAQ:CMRX): What We’re Looking For From Its Upcoming Data (NASDAQ:CMRX) - August 23 at 8:30 AM logoETF’s with exposure to Chimerix, Inc. : August 15, 2016 (NASDAQ:CMRX) - August 15 at 11:34 AM logoCHIMERIX INC Financials (NASDAQ:CMRX) - August 13 at 4:17 PM logoChimerix, Inc. :CMRX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:CMRX) - August 12 at 4:19 PM logoNotable Stocks within Analysts Radar: Chimerix, Inc. (NASDAQ:CMRX) , Becton, Dickinson and Company (NYSE:BDX) - Street Updates (NASDAQ:CMRX) - August 9 at 5:17 PM logoEdited Transcript of CMRX earnings conference call or presentation 8-Aug-16 12:30pm GMT (NASDAQ:CMRX) - August 8 at 9:41 PM logoChimerix Inc.: Chimerix Announces Second Quarter 2016 Financial Results (NASDAQ:CMRX) - August 8 at 9:08 AM logoChimerix reports 2Q loss (NASDAQ:CMRX) - August 8 at 9:07 AM logo7:47 am Chimerix reports Q2 EPS of ($0.39) vs ($0.51) Capital IQ Consensus Estimate; revs $1.84 mln vs $2.07 mln Capital IQ Consensus Estimate (NASDAQ:CMRX) - August 8 at 9:07 AM logoCHIMERIX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:CMRX) - August 8 at 9:07 AM logoChimerix Inc. (CMRX) Jumps 6.82% on August 03 - (NASDAQ:CMRX) - August 5 at 12:04 PM logoChimerix to Announce Second Quarter 2016 Financial Results on August 8, 2016 (NASDAQ:CMRX) - August 1 at 8:21 AM logoWill Chimerix, Inc. (NASDAQ:CMRX) Surprise Analysts? - Investor Newswire (NASDAQ:CMRX) - July 28 at 5:22 PM logoBrokers Issue Average Price Target Of 21.27 On Chimerix, Inc. (CMRX) - Fiscal Standard (NASDAQ:CMRX) - July 22 at 11:34 AM logoChimerix, Inc. (NasdaqGM:CMRX) Fundamental Star Rating Report - CML News (NASDAQ:CMRX) - July 22 at 11:34 AM
News IconEquity Roundup: Stock Performance Focus on Chimerix, Inc. (NASDAQ:CMRX) - Press Telegraph (NASDAQ:CMRX) - July 19 at 4:23 PM logoETF’s with exposure to Chimerix, Inc. : July 18, 2016 (NASDAQ:CMRX) - July 18 at 1:35 PM
News IconWere Analysts Bullish Chimerix Inc (NASDAQ:CMRX) This Week? - Consumer Eagle (NASDAQ:CMRX) - July 17 at 8:55 AM
News IconShares Experiencing a Downtrend: Chimerix, Inc. (NASDAQ:CMRX) - TGP (NASDAQ:CMRX) - July 16 at 6:49 AM logoChimerix Inc. (CMRX) Jumps 5.51% on July 15 - (NASDAQ:CMRX) - July 16 at 6:49 AM
News IconCrowd Rating and Earnings Recap for Chimerix, Inc. (NASDAQ:CMRX) - Telanagana Press (NASDAQ:CMRX) - July 15 at 10:52 AM logoBroker Outlook For Chimerix, Inc. (CMRX) - Fiscal Standard (NASDAQ:CMRX) - July 14 at 8:59 AM
News IconTrading Performance and Target Watch for Chimerix, Inc. (NASDAQ:CMRX) - Press Telegraph (NASDAQ:CMRX) - July 12 at 8:34 AM logoChimerix, Inc. (CMRX) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CMRX) - July 12 at 8:34 AM
News IconInsiders Increasing Positions in: Chimerix, Inc. (NASDAQ:CMRX) - Press Telegraph (NASDAQ:CMRX) - July 7 at 9:33 PM


Chimerix (NASDAQ:CMRX) Chart for Friday, October, 21, 2016

Last Updated on 10/21/2016 by Staff